Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,447 signal articles · 141 in last 24h · 154,069 total before filter · latest 56m ago
141last 24h
873last 7d
146● bullish (7d)
98● bearish (7d)
214publishers
AllMacro206Earnings108M&A125Regulatory22Product21Analyst17
✕ clear all filtersticker: MSFTSentiment:bullishneutralbearishshow all (incl. clickbait)
The $1.5 Trillion Question Nvidia’s Earnings Can’t Answer
The Wall Street Journal29d agoneutral
The $1.5 Trillion Question Nvidia’s Earnings Can’t Answer

​📈 Follow our live markets data and coverage. When tech companies started amping up spending on AI about three years ago, David Cahn, a venture capitalist at Sequoia Capital, asked a simple question: What was the gap between AI investment and the revenue generated from AI? It certainly won’t weigh on investors this afternoon, when Nvidia —the main chip supplier to the AI boom—reports quarterly results.

Nvidia Could Drop 20% On Poor Earnings
24/7 Wall St.31d agobearish
Nvidia Could Drop 20% On Poor Earnings

Nvidia enters earnings week with its stock priced for perfection, but a single crack in its numbers could send investors scrambling for the exits. The question is whether any weakness even exists, and what happens if the market finds out the hard way.

What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For Shareholders
Simply Wall St.34d agoneutral
What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For Shareholders

In recent months, Biogen raised its non-GAAP earnings guidance after strong commercial execution and a pivot toward growth products helped counter ongoing declines in its legacy multiple sclerosis portfolio. This improved outlook, combined with investor attention on five upcoming Phase 3 readouts in lupus, transplant, and rare disease programs, has become a central focus in reassessing the company’s long-term profile. Next, we’ll examine how Biogen’s higher earnings guidance and advancing...

Q2 Earnings Season Standout Performers: PLTR, MSFT
Zacks38d agoneutral
Q2 Earnings Season Standout Performers: PLTR, MSFT

The Q2 earnings season continues to wind down, which has overall shown immense strength with outsized growth. There have been several standout releases during the Q2 earnings cycle, including those from Palantir (PLTR) and Microsoft (MSFT).

Nvidia earnings preview: What’s next for Nvidia stock
Yahoo Finance Video41d agoneutralVIDEO
Nvidia earnings preview: What’s next for Nvidia stock

Yahoo Finance Market and Data Editor Jared Blikre and Senior Business Reporter Ines Ferre join the Executive Editor Brian Sozzi on the Opening Bid panel to preview Nvidia's (NVDA) upcoming earnings and assess what could be next for stock in the weeks ahead.

Pershing Square Q2 Earnings Call Highlights
MarketBeat41d agoneutral
Pershing Square Q2 Earnings Call Highlights

Pershing Square (NYSE:PS) held its first earnings call as a public company, with Chairman and CEO Bill Ackman emphasizing the firm’s strategy of generating growth through the compounding value of its existing investment portfolios while selectively launching new vehicles. Ackman said the firm’s per